+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model



Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model



Peptides 27(5): 980-989



In order to elucidate the mechanisms of the neuronal anti-opioid activity of Neuropeptide FF, we have transfected the SH-SY5Y neuroblastoma cell line, which expresses mu- and delta-opioid receptors, with the human NPFF1 receptor. The SH1-C7 clone expresses high affinity NPFF1 receptors in the same range order of density as opioid receptors. Similarly to the opioids, acute stimulation with the NPFF1 agonist NPVF inhibits adenylyl cyclase activity and voltage-gated (N-type) Ca2+ currents and enhances the intracellular Ca2+ release triggered by muscarinic receptors activation. In contrast, preincubation of cells with NPVF decreases the response to opioids on both calcium signaling, thus reproducing the cellular anti-opioid activity described in neurons. SH1-C7 cells are therefore a suitable model to investigate the interactions between NPFF and opioid receptors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011765184

Download citation: RISBibTeXText

PMID: 16488058

DOI: 10.1016/j.peptides.2005.07.025


Related references

Intact cell binding and the relation to opioid activities in SH-SY5Y cells. Journal of Pharmacology and Experimental Therapeutics 273(2): 721-727, 1995

Interaction of ketamine with mu2 opioid receptors in SH-SY5Y human neuroblastoma cells. Journal of Anesthesia 13(2): 107-109, 1999

Coincident signalling between delta-opioid and muscarinic receptors in SH-SY5Y cells. British Journal of Pharmacology 120(PROC Suppl. ): 125P, 1997

Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine and naloxonazine. Biochemical Society Transactions 21(4): 469S, 1993

Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine. European Journal of Pharmacology 268(3): 447-450, 1994

Regulation of STAT3 by mu-opioid receptors in human neuroblastoma SH-SY5Y cells. Neuroreport 15(9): 1431-1435, 2004

Mu-2-opioid receptors couple to phospholipase C in SH-SY5Y human neuroblastoma cells. British Journal of Anaesthesia 75(5): 662P-663P, 1995

Monoclonal anti opioid anti idiotypic antibodies which recognize opioid receptors. Federation Proceedings 46(4): 1310, 1987

Internalization of mu opioid receptors by endomorphin 1 and morphine in sh sy5y human neuroblastoma cells. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 248 12, 2002

Tyr-D-Arg2-Phe-sarcosine4 activates phospholipase C-coupled mu2-opioid receptors in SH-SY5Y cells. European Journal of Pharmacology 305(1-3): 235-238, 1996

Interaction among mu-opioid receptors and alpha 2-adrenoceptors on SH-SY5Y human neuroblastoma cells. European Journal of Pharmacology 227(1): 19-24, 1992

Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. Journal of Neurochemistry 65(1): 170-175, 1995

Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Research 1028(2): 121-132, 2004

Evidence for cross-talk between opioid and muscarinic receptors in SH-SY5Y human neuroblastoma cells. Society for Neuroscience Abstracts 25(1-2): 1193, 1999

Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors. Journal of Medicinal Chemistry 50(22): 5528-5532, 2007